aNeurogenetics Section, Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health

bDepartment of Psychiatry, University of Toronto

cInstitute of Medical Science, Faculty of Medicine, University of Toronto

dLaboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

eStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA

fThe Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

gProgram in Genetics and Genomic Biology and Department of Psychiatry, The Hospital for Sick Children

hDepartment of Psychiatry, Frederick W. Thompson Anxiety Disorders Centre, Sunnybrook Health Science Centre, Toronto, ON, Canada

iDepartment of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA

jDepartment of Psychiatry & Behavioral Neurosciences, Wayne State University, Detroit, Michigan, USA

Received 13 January 2023 Accepted 29 March 2023.

Correspondence to Dr. Gwyneth Zai, MD, FRCPC, PhD, Neurogenetics Section, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON M5 1R8, Canada Tel: 1 + 416 535 8501; fax: +1 416 979 4666; e-mail: [email protected]